市場調查報告書
商品編碼
1245711
2022-2028 年全球內窺鏡流體管理市場規模、份額、行業趨勢分析報告,按應用、產品、最終用戶、地區展望和預測Global Endoscopy Fluid Management Market Size, Share & Industry Trends Analysis Report By Application, By Product, By End User, By Regional Outlook and Forecast, 2022 - 2028 |
在預測期內,內窺鏡流體管理的全球市場規模預計將以 7.2% 的複合年增長率增長,到 2028 年將達到 9.7 億美元。
液體吸收增加與宮內壓高、子宮肌層深、宮內壓高和子宮大有關。 進行泌尿科內窺鏡檢查以診斷與泌尿道相關的問題。 內窺鏡檢查有兩種類型:輸尿管鏡檢查和膀胱鏡檢查。 膀胱鏡檢查膀胱和尿道內部,輸尿管鏡檢查輸尿管和腎臟內部。
技術進步使侵入性泌尿外科手術成為可能。 它的特點是並發症風險低,手術效率高。 例如,從尿道取出腎結石的手術。 一種醫用泵,可在內窺鏡手術期間在壓力下將流體輸送到手術區域。 關節鏡有助於治療前交叉韌帶損傷,這是職業運動中的一種主要損傷。 流體管理系統壓力設置得盡可能低或根據能見度要求設置。
COVID-19 影響分析
COVID-19 給世界各地的醫療保健系統帶來壓力。 這種流行病改變了醫療設備製造商和醫療保健提供者處理內窺鏡流體管理系統的方式。 COVID-19 大流行影響了許多專科醫師和程序相關領域,例如胃腸病學。 重組了大量醫院和診所,以提高其為診斷出患有 COVID-19 的患者提供服務的能力。 此外,預計這些內窺鏡手術中有很大一部分會因封鎖而受到影響,這將對內窺鏡流體管理市場的增長產生不利影響。
市場增長因素
由於微創手術的增多
與傳統的開放手術相比,微創手術的創傷要小得多。 使用傳統腹腔鏡器械進行的手術具有創傷性和復雜性。 然而,在微創手術中,通過一個小切口插入腹腔鏡攝像機,並使用小型專用儀器進行手術。 此外,疼痛更少,患者恢復得更快。 更快的恢復、更小的切口、更高的準確性、更短的住院時間、更少的疤痕和更少的疼痛使得這些手術越來越受歡迎。 此外,這些醫療顯示器甚至可以提供細胞和組織中最細微的差異,確保出色的可視性並實現快速和精確的手術。 這支持了本地市場的增長。
胃腸道癌患者數量增加
我們發現胃腸道癌症的負擔正在轉移到發展中經濟體,這些國家通常缺乏醫療資源來應對日益增加的患病率。 預計五種主要胃腸道癌症類型中每一種的新病例和死亡人數都會增加。 這種癌症還與感染、吸煙、節食、缺乏運動、飲酒和肥胖有關。 胃腸道癌症病例的增加,尤其是在新興國家,將促進內窺鏡液體管理的使用,這將推動預測期內的市場擴張。
市場製約因素
內窺鏡檢查的替代方法
接受內窺鏡檢查的患者通常會被麻醉或輕度鎮靜,因為這對許多患者來說可能會感到不舒服和疼痛。大多數接受掃描的人不需要鎮靜劑。 此外,幾乎任何年齡的人都可以進行 CT 掃描,而內窺鏡檢查主要針對成年人。 由於 CT 掃描無痛且不需要鎮靜,因此它們是內窺鏡檢查的潛在替代品,預計內窺鏡檢查會阻礙液體管理的市場增長。
產品展望
根據產品,內窺鏡流體管理市場分為系統和配件。 在 2021 年的內窺鏡流體管理市場中,配件部分佔據了很大的收入份額。 這是因為這些附件用於治療和組織樣本採集。 內窺鏡具有通道,醫生可以通過這些通道將工具插入患者體內。 這些工具包括用於採集組織樣本的柔性鑷子、用於去除可疑生長物的活檢鉗、用於採集細胞樣本的細胞學刷以及用於去除體內縫線的縫線去除鉗。我有。
應用展望
根據應用,內窺鏡流體管理市場分為腹腔鏡、宮腔鏡和其他。 到 2021 年,腹腔鏡細分市場將在內窺鏡流體管理市場中佔據最高的收入份額。 這是由於越來越多的腹腔鏡手術。 許多人現在選擇微創手術進行診斷和治療。 此外,全球老齡化人口正在增加,進一步增加了對內窺鏡流體管理系統的需求。 預計這些因素將在預測期內推動該細分市場的增長。
最終用戶視角
按最終用戶劃分,內窺鏡流體管理市場分為醫院、診所和其他。 醫院部門將在 2021 年以最大的收入份額引領內窺鏡流體管理市場。 這是由於在此類醫療機構中接受大量外科手術的患者數量不斷增加。 內窺鏡手術正在增加,先進的醫院正在發展。 此外,許多政府機構正著力加強手術能力。 預計這些因素將加速該行業的擴張。
區域展望
按地區分析了北美、歐洲、亞太地區和 LAMEA 的內窺鏡液體管理市場。 到 2021 年,北美地區將佔據內窺鏡流體管理市場的最高收入份額。 這是由於這些系統提供的幫助可維持正確的壓力以減少內窺鏡手術期間的內腔出血。 高科技設備的使用提高了治療的依從性。 該地區還擁有高技能的醫療隊伍、高科技技術和強大的醫療保健基礎設施。 此外,政府為進一步加強該行業而出台的多項政策預計將提高該地區醫療器械的利用率並促進市場增長。
市場進入者採取的主要策略是產品發布。 發表在 Cardinal Matrix 上的一項分析表明,美敦力 PLC 是內窺鏡液體管理市場的先驅。 Olympus Corporation、Stryker Corporation 和 Hologic, Inc. 等公司是內窺鏡流體管理市場的領先創新者。
The Global Endoscopy Fluid Management Market size is expected to reach $970 Million by 2028, rising at a market growth of 7.2% CAGR during the forecast period.
Endoscopy fluid management is a medical device that assists in managing fluids during endoscopic procedures. These systems generally contain a suction device, a fluid collection unit, and a disposable fluid system. the fluid collection unit collects and stores fluid during endoscopic procedures. The suction device are used to remove fluids from the patient's body and carry them to the fluid collection unit. The disposable fluid system treats and disposes of the collected fluids in a manner that is environment friendly.
An endoscopy fluid management system is required in all endoscopy procedures, including laparoscopy, arthroscopy, hysteroscopy, and urology. A laparoscopy is a surgical, diagnostic procedure conducted utilizing laparoscopy and aids in evaluating the organs inside the abdomen. It's a minimally invasive procedure that needs only small incisions. In hysteroscopy, systemic absorption of the uterine distension fluid occurs majorly through disrupted endometrial and myometrial venous sinuses due to the pressure gradient between the uterine cavity and open vessels or sinuses.
The increased fluid absorption is linked with high intrauterine pressure, deep myometrial penetration, higher intrauterine pressure, and large uteri. Urology endoscopies are done to diagnose the issues related to the urinary tract. Endoscopies come in two forms one is ureteroscopy, and the other is cystoscopy. A cystoscopy utilizes a cystoscope to look inside the bladder and urethra, whereas a ureteroscopy utilizes a ureteroscopy to look inside the ureters and kidneys.
With technological advancements, it is possible to conduct invasive urological surgeries. Lower risk of complications and high efficiency characterizes them. For instance, the removal of kidney stones through the urethra. A medical pump is designed to deliver fluid under pressure to an operating area during endoscopy. Arthroscopy aids in treating anterior cruciate ligament (ACL) injury, a significant injury in professional sports. Fluid management system pressure is set as low as possible or per the requirement to obtain a view.
COVID-19 Impact Analysis
COVID-19 has put the healthcare system under stress around the world. The pandemic has altered how medical device manufacturers and healthcare providers approach endoscopy fluid management systems. The COVID-19 pandemic affected numerous sub-specialists and procedure-related fields such as gastroenterology. A considerable number of hospitals and clinics were restructured to raise their capacity for the patient diagnosed with COVID-19. In addition, a significant proportion of these endoscopic procedures were affected due to the lockdowns, which is expected to have a negative impact on the growth of the endoscopy fluid management market.
Market Growth Factors
The increasing number of minimally invasive surgeries
Surgeries which are minimally invasive are much less traumatic than conventional open surgeries. Surgeries performed with traditional laparoscopic instruments were traumatic and complex. But in minimally invasive surgeries, laparoscopic cameras are inserted through smaller incisions, and small specialized instruments are utilized to perform the operation. The recovery is also less painful, and patients recover faster. The popularity of these surgeries are increasing due to the quicker recovery, smaller incisions, high accuracy, shorter hospital stays, and less scarring & pain. In addition, these medical displays provide even the most negligible difference in cells and tissues, ensure superior visibility, and enable rapid and precise surgery. This supports the growth of the regional market.
The rising cases of gastrointestinal cancer
It was seen that the burden of GI cancers has continued to shift towards economically developing nations which usually have fewer healthcare resources to manage the rising incidence. The number of new cases and death for each type of the five major types of GI cancers are expected to increase. This cancer is also associated with infection, tobacco smoking, diet, physical inactivity, alcohol consumption, and obesity. The increasing cases of GI cancers, especially in developing countries, will surge the utilization of endoscopy fluid management, boosting the market expansion in the projected period.
Market Restraining Factors
Alternatives to endoscopy
Patients undergoing endoscopy are generally provided with anesthetic or are mildly sedated as the procedure might be uncomfortable or painful to many patients, while almost all individuals undergoing a CT scan don't require any sedation. In addition, CT scans can be done on people of nearly every age, while most endoscopy procedures are done on adults. The painlessness and the requirement of no type of sedatives in the CT scans might make them a better alternative to endoscopy; hence the market growth for endoscopy fluid management is expected to hinder.
Product Outlook
Based on product, the endoscopy fluid management market is segmented into system and accessories. The accessories segment acquired a substantial revenue share in the endoscopy fluid management market in 2021. This is due to the usage of these accessories to provide treatment or collect tissue samples. An endoscope has a channel through which the doctor can insert tools into the patient's body. These tools include flexible forceps, which take the tissue sample; biopsy forceps which are used to remove any suspicious growth; cytology brushes which take the cell sample and suture removal forceps, which are used to remove stitches inside the body.
Application Outlook
On the basis of application, the endoscopy fluid management market is divided into laparoscopy, hysteroscopy and others. The laparoscopy segment held the highest revenue share in the endoscopy fluid management market in 2021. This is because of the increasing number of laparoscopy procedures. Many individuals are now opting for minimally invasive procedures for diagnosis and treatment. In addition, the rising geriatric population globally is further increasing the demand for endoscopy fluid management systems. These factors are anticipated to propel the segment's growth during the projected period.
End User Outlook
By end user, the endoscopy fluid management market is classified into hospital, clinics and others. The hospital segment led the endoscopy fluid management market by generating the maximum revenue share in 2021. This is due to the rising number of patient admissions for numerous surgical procedures in such healthcare settings. There is an increase in endoscopy procedures and the development of advanced hospitals. Also, many governmental bodies are now concentrating on enhancing the capacity for surgical procedures. These factors are anticipated to surge the expansion of the segment.
Regional Outlook
Region-wise, the endoscopy fluid management market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the endoscopy fluid management market in 2021. This is due to the assistance provided by these systems in maintaining precise pressure to decrease the bleeding in internal cavities during endoscopic procedures. Utilizing high-tech devices enhances treatment compliance. The region also has highly skilled medical professionals, high-tech technology, and a robust healthcare infrastructure. Also, many policies by the government to further enhance the sector is expected to increase their utilization and propel the market growth in the region.
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Medtronic PLC is the forerunners in the Endoscopy Fluid Management Market. Companies such as Olympus Corporation, Stryker Corporation, Hologic, Inc. are some of the key innovators in Endoscopy Fluid Management Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, Steris PLC, B. Braun Melsungen AG, Stryker Corporation, Hologic, Inc., ConMed Corporation, Karl Storz SE & Co. KG, Arthrex, Inc., and COMEG Medical Technologies (Acteon Group).
Strategies Deployed in Endoscopy Fluid Management Market
2022-Dec: Olympus came into an agreement to acquire Odin Vision, a UK-based cloud-AI endoscopy start-up. Through this acquisition, Olympus aims to strengthen its capabilities to deliver data-driven insights and advanced AI-powered solutions which can transform patient care and enhance clinical and procedural workflows.
2022-Feb: Stryker took over Vocera Communications, Inc., a company involved in digital care coordination and communication. Through this acquisition, Stryker would advance innovations and boost its digital aspirations. Additionally, both companies would work together to allow safer patient care and support their customers to enhance outcomes.
2021-Nov: Medtronic received FDA approval for PillCam Small Bowel 3 system. The PillCam SB3 integrates Medtronic's PillCam technology with Amazon logistics, integration developed to ensure both timely and precise results for patients from the convenience of their homes.
2021-Oct: Arthrex expanded its global footprint by setting up a new facility in Anderson County, United States. The new plant is expected to create 500 new jobs. The new plant reflects Arthrex's commitment to manufacturing supreme quality products in the United States and further aids Arthrex in the growth and development of new products.
2021-Jun: STERIS plc took over Cantel Medical, a provider of infection prevention products and services to dental, dialysis, endoscopy, and life sciences Customers. This acquisition would complement and broaden Steris's product and service portfolio, customers, and global.
2021-Apr: Medtronic released GI Genius, a medical device that utilizes artificial intelligence to assist clinicians to identify in real-time any potential irregularities in the colon during colonoscopies. Colonoscopies allow gastroenterologists to detect polyps and lesions that might develop into cancer as a means of screening and surveillance.
2020-Oct: Olympus Corporation launched ENDO-AID, a product that allows real-time display of automatically detected suspicious lesions. ENDO-AID works together with the newly released EVIS X1, Olympus' most advanced endoscopy system to date.
2020-Mar: KARL STORZ unveiled TELE PACK + system, a mobile, compact endoscopy system. The product is a portable video system created to integrate all the important components, consisting of the camera control unit, light source, and display needed for endoscopic diagnosis and treatment, including data management and image capture.
2018-Aug: Hologic launched the Fluent system, a fluid management system for hysteroscopic procedures across the United States. The product is developed in response to the issues faced by doctors and nurses performing hysteroscopies. The Fluent System consists of advanced technology with a modernized design for highly efficient fluid monitoring during procedures.
2018-May: Olympus unveiled DualKnife JTM, an endoscopic submucosal dissection (ESD) electrosurgical knife. The product combines submucosal injection to assist safe, efficient, and highly reliable ESD performance.
Market Segments covered in the Report:
By Application
By Product
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures